Open official notice

0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg 30 mL (5 mg mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19), packaged in 25

Official notice

9 Jun 2021

RecallScope risk estimate:CriticalFDA

An official FDA notice concerns 0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg 30 mL (5 mg mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19), packaged in 25. Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP Published 2021-06-09.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

163,957

Recall number

D-0626-2021

Official notice

2021-06-09

The hazard

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

EG6023

Event Ids

87837

Recall Numbers

D-0626-2021

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19), packaged in 25 vials per tray (NDC 0409-1162-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.

Units affected

163,957

Hazard

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Brand

Manufacturer

PFIZER, INC

Phone

Not provided

Brand: Pfizer. Contact: PFIZER, INC.

Source & status

Source

Tier

official

Category

Health

Official classification

Class I

Recall details

Recall number

D-0626-2021

Event ID

87837

Units affected

163,957

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 9 Jun 2021. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button